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Objective
Assess adherence and determine the reasons of poor
adherence in HIV-1 infected children taking once-a-day
paediatric HAART with DDI+3TC+EFV in Bobo-Diou-
lasso, Burkina Faso.
Methods
Fifty-two HIV-1 infected children were followed during a
12-month period of the II phase clinical trial. Adherence
was assessed using monthly pill counts. A questionnaire
was administered quarterly in order to investigate reasons
of poor adherence.
Results
During the 12 months of follow up, two children died.
Seven became resistant and 118 questionnaires were
administered. Only two caregivers declared missed tak-
ings the previous week, which was contrasting with the
counting. The difficulties reported by the caregivers were
related to the time slot, and the instruction to take the
pills on an empty stomach, the length of the treatment,
the ARV's form and palatability.
The adherence rate was 98% and 32% of the patients had
always had an adherence rate ≥ 95%. The adherence was
not correlated to the socio-demographic factors and to the
immuno-virological response.
Conclusion
Good adherence of this once daily's treatment study. No
association between adherence, the socio-demographic
factors and the infection's markers.
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